These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6742821)

  • 21. The limited effect of nasal interferon induced by rhinovirus and a topical chemical inducer on the course of infection.
    Gatmaitan BC; Stanley ED; Jackson GG
    J Infect Dis; 1973 Apr; 127(4):401-7. PubMed ID: 4348496
    [No Abstract]   [Full Text] [Related]  

  • 22. The formation of interferon during acute respiratory virus infection of volunteers.
    Smorodintsev AA; Beare AS; Bynoe ML; Head B; Tyrrell DA
    Arch Gesamte Virusforsch; 1971; 33(1):9-16. PubMed ID: 4325979
    [No Abstract]   [Full Text] [Related]  

  • 23. Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus.
    Shibayama Y; Skoner D; Suehiro S; Konishi JE; Fireman P; Kaplan AP
    Immunopharmacology; 1996 Jun; 33(1-3):311-3. PubMed ID: 8856172
    [No Abstract]   [Full Text] [Related]  

  • 24. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds.
    Gaffey MJ; Gwaltney JM; Dressler WE; Sorrentino JV; Hayden FG
    Am Rev Respir Dis; 1987 Jan; 135(1):241-4. PubMed ID: 3800150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.
    Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM
    N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purified interferon as protection against rhinovirus infection.
    Scott GM; Phillpotts RJ; Wallace J; Secher DS; Cantell K; Tyrrell DA
    Br Med J (Clin Res Ed); 1982 Jun; 284(6332):1822-5. PubMed ID: 6177374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure to demonstrate synergy between interferon-alpha and a synthetic antiviral, enviroxime, in rhinovirus infections in volunteers.
    Higgins PG; Barrow GI; al-Nakib W; Tyrrell DA; DeLong DC; Lenox-Smith I
    Antiviral Res; 1988 Nov; 10(1-3):141-9. PubMed ID: 3232968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds.
    Gwaltney JM; Park J; Paul RA; Edelman DA; O'Connor RR; Turner RB
    Clin Infect Dis; 1996 Apr; 22(4):656-62. PubMed ID: 8729205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of experimental rhinovirus 39 infection on the nasal response to histamine and cold air challenges in allergic and nonallergic subjects.
    Doyle WJ; Skoner DP; Seroky JT; Fireman P; Gwaltney JM
    J Allergy Clin Immunol; 1994 Feb; 93(2):534-42. PubMed ID: 8120280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans.
    Treanor JJ; Betts RF; Erb SM; Roth FK; Dolin R
    J Infect Dis; 1987 Aug; 156(2):379-83. PubMed ID: 3598236
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of alpha 2-interferon against the common cold.
    Foy HM; Fox JP; Cooney MK
    N Engl J Med; 1986 Aug; 315(8):513-4. PubMed ID: 3736634
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections.
    Igarashi Y; Skoner DP; Doyle WJ; White MV; Fireman P; Kaliner MA
    J Allergy Clin Immunol; 1993 Nov; 92(5):722-31. PubMed ID: 8227864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects on the nasal mucosa of upper respiratory viruses (common cold).
    Winther B
    Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha 2.
    Hayden FG; Gwaltney JM
    Antiviral Res; 1983 Mar; 3(1):67-71. PubMed ID: 6307140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental common cold increases mucosal output of eotaxin in atopic individuals.
    Greiff L; Andersson M; Andersson E; Linden M; Myint S; Svensson C; Persson CG
    Allergy; 1999 Nov; 54(11):1204-8. PubMed ID: 10604558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of experimental coronavirus colds with intranasal alpha-2b interferon.
    Turner RB; Felton A; Kosak K; Kelsey DK; Meschievitz CK
    J Infect Dis; 1986 Sep; 154(3):443-7. PubMed ID: 3016111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinins are generated in nasal secretions during natural rhinovirus colds.
    Proud D; Naclerio RM; Gwaltney JM; Hendley JO
    J Infect Dis; 1990 Jan; 161(1):120-3. PubMed ID: 2295843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of nasal biopsies during rhinovirus experimental colds.
    Fraenkel DJ; Bardin PG; Sanderson G; Lampe F; Johnston SL; Holgate ST
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1130-6. PubMed ID: 7921447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral titers in nasal lining fluid compared to viral titers in nasal washes during experimental rhinovirus infection.
    Hendley JO; Gwaltney JM
    J Clin Virol; 2004 Aug; 30(4):326-8. PubMed ID: 15163422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection.
    Monto AS; Shope TC; Schwartz SA; Albrecht JK
    J Infect Dis; 1986 Jul; 154(1):128-33. PubMed ID: 3011917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.